Showing results (51-60 of 670) with videos related to
Sort By:
Pageof 67
APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica|August 1, 1992
The prevalence of selective IgA deficiency in type 1 diabetes mellitusR S Liblau, S Caillat-Zucman, A M Fischer, et al.Diabetic Medicine : a Journal of the British Diabetic Association|January 26, 2012
Pancreatic exocrine function in patients with diabetesE Larger, M F Philippe, L Barbot-Trystram, et al.Molecular Immunology|October 1, 1993
Evidence for antigen driven selection in two monoclonal auto-antibodies derived from nonobese diabetic miceJ M Pléau, P N Marche, M P Serrano, et al.Diabetes & Metabolism|August 2, 2011
Ambulatory 24-hour fast using flexible insulin therapy in patients with type 1 diabetesC Vigeral, A Sola-Gazagnes, S Nejjar, et al.European Journal of Immunology|May 1, 1991
Anti-alpha/beta T cell receptor monoclonal antibody provides an efficient therapy for autoimmune diabetes in nonobese diabetic (NOD) miceP Sempé, P Bédossa, M F Richard, et al.La Revue De Medecine Interne|January 1, 1997
[Emphysematous pyelonephritis in diabetics]C Pagnoux, J B Cazaala, A Méjean, et al.The Journal of Clinical Investigation|December 1, 1987
Effect of cyclosporin A treatment on the production of antibody in insulin-dependent (type I) diabetic patientsC Boitard, G Feutren, L Castano, et al.Journal of Autoimmunity|April 1, 1991
Prevention of diabetes in NOD mice treated with antibody to murine IFN gammaM Debray-Sachs, C Carnaud, C Boitard, et al.International Immunology|May 1, 1993
Role of CD4+CD45RA+ T cells in the development of autoimmune diabetes in the non-obese diabetic (NOD) mouseP Sempé, S Ezine, J Marvel, et al.Immunogenetics|January 1, 1990
Heterogeneity of HLA genetic factors in IDDM susceptibilityM Martell, A Marcadet, A Moine, et al.Pageof 67